Bayesian Designs for Phase I-II Clinical Trials Bayesian Designs for Phase I-II Clinical Trials
Chapman & Hall/CRC Biostatistics Series

Bayesian Designs for Phase I-II Clinical Trials

Ying Yuan y otros
    • USD 54.99
    • USD 54.99

Descripción editorial

Reliably optimizing a new treatment in humans is a critical first step in clinical evaluation since choosing a suboptimal dose or schedule may lead to failure in later trials. At the same time, if promising preclinical results do not translate into a real treatment advance, it is important to determine this quickly and terminate the clinical evaluation process to avoid wasting resources.

Bayesian Designs for Phase I–II Clinical Trials describes how phase I–II designs can serve as a bridge or protective barrier between preclinical studies and large confirmatory clinical trials. It illustrates many of the severe drawbacks with conventional methods used for early-phase clinical trials and presents numerous Bayesian designs for human clinical trials of new experimental treatment regimes.

Written by research leaders from the University of Texas MD Anderson Cancer Center, this book shows how Bayesian designs for early-phase clinical trials can explore, refine, and optimize new experimental treatments. It emphasizes the importance of basing decisions on both efficacy and toxicity.

GÉNERO
Ciencia y naturaleza
PUBLICADO
2017
19 de diciembre
IDIOMA
EN
Inglés
EXTENSIÓN
324
Páginas
EDITORIAL
CRC Press
VENDEDOR
Taylor & Francis Group
TAMAÑO
17.4
MB

Más libros de Ying Yuan, Hoang Q. Nguyen & Peter F. Thall

Otros libros de esta serie

Statistical Design, Monitoring, and Analysis of Clinical Trials Statistical Design, Monitoring, and Analysis of Clinical Trials
2021
Statistical Thinking in Clinical Trials Statistical Thinking in Clinical Trials
2021
Signal Detection for Medical Scientists Signal Detection for Medical Scientists
2021
Single-Arm Phase II Survival Trial Design Single-Arm Phase II Survival Trial Design
2021
Medical Statistics for Cancer Studies Medical Statistics for Cancer Studies
2022
Analyzing Longitudinal Clinical Trial Data Analyzing Longitudinal Clinical Trial Data
2016